| 今开：14.9 | 昨收：14.56 |
| 最高：15.97 | 最低：14.785 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：8.26633541E8 |
Stoke Therapeutics(STOK)05-21 04:25
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003917 Act: 33 Size: 5 KB 网页链接查看全文
Stoke Therapeutics(STOK)07-09 04:35
$Stoke Therapeutics(STOK)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008222 Act: 34 Size: 13 KB 网页链接查看全文
Stoke Therapeutics(STOK)06-14 04:15
$Stoke Therapeutics(STOK)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-160696 Act: 33 Size: 245 KB 网页链接查看全文
Stoke Therapeutics(STOK)06-08 04:25
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015970 Size: 12 KB 网页链接查看全文
Stoke Therapeutics(STOK)06-08 04:45
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015995 Size: 8 KB 网页链接查看全文
Stoke Therapeutics(STOK)05-18 04:15
$Stoke Therapeutics(STOK)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-013475 Size: 10 KB 网页链接查看全文
Stoke Therapeutics(STOK)06-08 04:35
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015976 Size: 12 KB 网页链接查看全文
Stoke Therapeutics(STOK)06-08 04:35
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015974 Size: 12 KB 网页链接查看全文
Stoke Therapeutics(STOK)06-08 04:45
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016010 Size: 8 KB 网页链接查看全文
Stoke Therapeutics(STOK)05-23 04:25
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014087 Size: 14 KB 网页链接查看全文
美股指南2019-06-17 20:34
摘要: 医药股 Stoke Therapeutics，Inc 于06月19 美股上市,价格为: 14.00-16.00美元; 股票代码: $Stoke Therapeutics(STOK)$ ; IPO承销商: 摩根大通、考恩、瑞士信贷、Canaccord Genuity。 $京东(JD)$
公司简介
STOK正在开创一种通过精确调节蛋白质来治疗严重遗传疾病的新方法。目前STOK...查看全文
$Stoke Therapeutics(STOK)$ SC 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008222 Act: 34 Size: 13 KB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019168 Size: 9 KB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019169 Size: 7 KB 网页链接
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005205 Act: 33 Size: 5 KB 网页链接
$Stoke Therapeutics(STOK)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-165651 Act: 34 Size: 143 KB 网页链接
$Stoke Therapeutics(STOK)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001910 Act: 33 Size: 1 KB 网页链接
$Stoke Therapeutics(STOK)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-160696 Act: 33 Size: 245 KB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015995 Size: 8 KB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015998 Size: 8 KB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016005 Size: 8 KB 网页链接